Science represents an amazingly exciting frontier for AI, and AI represents the most exciting new instruments in the hands of ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

The race to draw the best and brightest students has become an international one, with candidates weighing options not only in their state or country, but also across the globe.